<DOC>
	<DOCNO>NCT00510393</DOCNO>
	<brief_summary>The Destiny trial compare use bare metal stent system drug elute stent system treatment infrapopliteal lesion patient Critical Limb Ischemia . It investigate whether difference 12 month angiographic patency stented area use 2 different stent system .</brief_summary>
	<brief_title>Drug Eluting Stents In The Critically Ischemic Lower Leg</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Stenotic ( &gt; 50 % ) occlusive atherosclerotic disease infrapopliteal arteries A maximum two focal target lesion one infrapopliteal vessel Length lesion maximally 40 mm , allow maximally 2 stent implanted Reference vessel diameter 23.5 mm Symptomatic critical limb ischemia ( Rutherford 4 , 5 ) The patient must &gt; 18 year age Lifeexpectancy 12 month The patient child bear potential negative serum pregnancy test within 7 day index procedure The patient must willing able return appropriate followup time duration study The patient must provide write patient informed consent approve ethic committee Patient refuse treatment The reference segment diameter suitable available stent design . Unsuccessfully treat ( &gt; 30 % residual stenosis ) proximal inflow limit arterial stenosis Untreatable lesion locate distal outflow artery More two infrapopliteal lesion limb Previously implant stent ( ) PTA lesion site Lesion location require kiss stent procedure Lesion lie within adjacent aneurysm Inflowlimiting arterial lesion leave untreated The patient know allergy heparin , Aspirin anticoagulant/antiplatelet therapy bleed diatheses unable , unwilling , tolerate therapy . The patient take Phenprocoumon ( Marcumar ) . The patient history prior lifethreatening contrast medium reaction . The patient currently enrol another investigational device drug trial . The patient currently breastfeed , pregnant intend become pregnant . The patient mentally ill retard . Subject receive heart transplant organ transplant wait list organ transplant Subject receiving schedule receive anticancer therapy malignancy within 30 day prior procedure Subject receive immunosuppression therapy , know serious immunosuppressive disease ( e.g. , human immunodeficiency virus ) , severe autoimmune disease require chronic immunosuppressive therapy ( e.g. , systemic lupus erythematosus , etc . ) The patient also receive inhibitor CYP3A ( Itraconazole , Erythromycin ) , inducer CYP3A ( Rifampin ) within 90 day follow procedure . Subject receive schedule receive chronic anticoagulation therapy ( e.g. , heparin , coumadin ) Use alternative therapy ( e.g . atherectomy , cut balloon , laser , radiation therapy ) part index procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Critical Limb Ischemia</keyword>
	<keyword>CLI</keyword>
	<keyword>Drug Eluting Stent</keyword>
	<keyword>DES</keyword>
	<keyword>Bare Metal Stent</keyword>
	<keyword>BMS</keyword>
</DOC>